Akums Drugs and Pharmaceuticals vs Nifty 50: Returns Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
Akums Drugs and Pharmaceuticals share price Rs 758.25 on NSE. Akums Drugs and Pharmaceuticals vs Nifty 50 over 1 year: +62.64% vs -2.41%. 52-week high Rs 769.45, low Rs 415.05.
Quick Answer
Akums Drugs and Pharmaceuticals vs Nifty 50 shows Akums Drugs and Pharmaceuticals ahead of the benchmark on a one-year view, gaining +62.64% against the Nifty 50’s -2.41%. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Akums Drugs and Pharmaceuticals’s trading liquidity, valuation and sector context rather than relying on returns alone.
Akums Drugs and Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Akums Drugs and Pharmaceuticals trades on the NSE under the symbol AKUMS, and its 1M return of +8.72% compares with the Nifty 50’s -1.44% over the same period.
The Akums Drugs and Pharmaceuticals vs Nifty 50 comparison matters because Akums Drugs and Pharmaceuticals is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Akums Drugs and Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.
Click Here – Get Free Investment Predictions
Akums Drugs and Pharmaceuticals vs Nifty 50: Performance at a Glance
The table below sets out Akums Drugs and Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 7 September 2026.
| Time Frame | Akums Drugs and Pharmaceuticals Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +8.72% | -1.44% | +10.16% pp |
| 3 Months | +39.04% | +2.78% | +36.26% pp |
| 6 Months | +58.1% | -3.35% | +61.45% pp |
| 1 Year | +62.64% (Akums Drugs and Pharmaceuticals) | -2.41% (Nifty 50) | +65.05% pp |
On the Akums Drugs and Pharmaceuticals vs Nifty 50 scorecard, Akums Drugs and Pharmaceuticals has stayed ahead of the index over the most recent one-year window. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock.
Check the Univest Screener for live Akums Drugs and Pharmaceuticals and Nifty 50 data
Why the Akums Drugs and Pharmaceuticals vs Nifty 50 Gap Exists
Akums Drugs and Pharmaceuticals’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Akums Drugs and Pharmaceuticals vs Nifty 50 return table above.
A second factor behind the Akums Drugs and Pharmaceuticals vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Akums Drugs and Pharmaceuticals’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Akums Drugs and Pharmaceuticals and Nifty 50 live on the go.
Akums Drugs and Pharmaceuticals vs Nifty 50: Has Akums Drugs and Pharmaceuticals Beaten the Benchmark?
Akums Drugs and Pharmaceuticals has beaten the Nifty 50 over the past year, gaining +62.64% against the index’s -2.41% over the same period.
Risks of the Akums Drugs and Pharmaceuticals vs Nifty 50 Comparison
Reading too much into a Akums Drugs and Pharmaceuticals vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Akums Drugs and Pharmaceuticals carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 415.05 to Rs 769.45 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Akums Drugs and Pharmaceuticals vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Akums Drugs and Pharmaceuticals vs Nifty 50 record should factor in Akums Drugs and Pharmaceuticals’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Akums Drugs and Pharmaceuticals outperformed the Nifty 50 in the last year?
Ans. Yes. Akums Drugs and Pharmaceuticals gained +62.64% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 7 September 2026.
What is the Akums Drugs and Pharmaceuticals share price today compared to Nifty 50?
Ans. Akums Drugs and Pharmaceuticals share price stood at Rs 758.25 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.
What is the 52-week high and low of Akums Drugs and Pharmaceuticals?
Ans. Akums Drugs and Pharmaceuticals’s 52-week high is Rs 769.45 and its 52-week low is Rs 415.05, based on NSE data.
Why does Akums Drugs and Pharmaceuticals show bigger price swings than the Nifty 50?
Ans. Akums Drugs and Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Akums Drugs and Pharmaceuticals’s price more sharply than the diversified index, a key reason the Akums Drugs and Pharmaceuticals vs Nifty 50 return gap varies across time frames.
Is Akums Drugs and Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?
Ans. Akums Drugs and Pharmaceuticals’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Akums Drugs and Pharmaceuticals vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
